Answer
The mean terminal half-life of esketamine after administration as Spravato nasal spray generally ranges from 7 to 12 hours.
Sources for this answer
- Spravato 28 mg nasal spray, solutionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §5.2 Pharmacokinetic properties · Version 12Document updated
Sources checked